| |
 |
Details: |
 |
|
|
Discovering, developing and commercializing new therapeutic agents.
|
| URL: |
http://www.collagenex.com/
|
| Title: |
Galderma USA: The leading pharmaceutical company devoted entirely to dermatology |
| Image: |
 |
| Description: |
Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Research and Development - Collagenex Pharmaceuticals. Discovering, developing and commercializing new therapeutic agents. |
| Similar: |
|
|
|
Related Sites |
|
MDL Information Systems, Inc. (Popularity:  ): MDL is a leading provider of integrated logistics and decision support systems that enable a high-throughput environment for research and ...
Karo Bio AB (Popularity: ): A drug discovery company focusing its research on the discovery and pre-clinical phases of drug development.
Mercodia (Popularity: ): Specialising in the research, development, and manufacture of quality in vitro diagnostics products.
Pherin Pharmaceutical (Popularity: ): Pherin Pharmaceuticals is focused on the discovery and development of vomeropherins, a new family of pharmaceutical compounds for the treatment ...
Maas BiolAB LLC (Popularity: ): Developing treatments for CNS disease.
Equi-Tox, Inc. (Popularity: ): Veterinary pharmaceutical research and development firm dedicated to solutions for fescue toxicosis and other animal problems, especially for equine.
Access Pharmaceuticals (Popularity: ): A broadly based emerging pharmaceutical company, with a balanced technology pipeline of novel low development risk product candidates and longer-term ...
Verne Mendel Medical Corporation (Popularity: ): Developing cause-oriented treatment for Parkinson's, Alzheimer's, and Lou Gehrig's diseases based on preventing mitochondrial DNA damage, the earliest recognized event ...
Astex Technology (Popularity: ): A structure-based drug discovery company pioneering the use of High Throughput X-ray crystallography (HTX) for the rapid identification of novel ...
Rentschler Biotechnology (Popularity: ): Your partner for contract development and production of biopharmaceuticals. The company is primarily engaged in development, clinical testing, production and ...
Pharmaceutics International, Inc. (Popularity: ): Core business is formulation development together with clinical trial material manufacturing and commercial manufacture of low volume products.
Cytochroma, Inc. (Popularity: ): Development stage pharmaceutical company focused on the identification of cytochrome P450 enzymes for development of drug candidates and diagnostics. Located ...
|
|
Popular Sites |
|
Mercodia (Popularity: ): Specialising in the research, development, and manufacture of quality in vitro diagnostics products.
Dr. J.R.K's Siddha Research & Pharmaceuticals Pvt. Ltd. (Popularity: ): Indian Pharmaceutical company manufacturing, marketing effective & safe herbal products for PSORIASIS, VITILIGO and any other skin aliments.
Karo Bio AB (Popularity: ): A drug discovery company focusing its research on the discovery and pre-clinical phases of drug development.
Diagnos-Techs, Inc. - Clinical and Research Laboratory (Popularity: ): Originators of clinical saliva testing for female and male hormones.
MDL Information Systems, Inc. (Popularity: ): MDL is a leading provider of integrated logistics and decision support systems that enable a high-throughput environment for research and ...
|
|
Related Press |
|
Great Lakes Pharmaceuticals, Inc., Announces $2.4 Million Equity Financing (Popularity: ): Great Lakes Pharmaceuticals, Inc. announced today the completion of Series A $2.4 million equity financing led by Ohio investment funds ...
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease (Popularity: ): Iodine has been used as an antimicrobial for the last century. Much has been written about molecular iodine yet many ...
Watson' Launches Generic Kadian(R) (Popularity: ): PARSIPPANY, N.J., Nov. 10, 2011 -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has received approval from the ...
Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis (Popularity: ): Cerimon Pharmaceuticals, Inc., announced today it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of ...
DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease (Popularity: ): Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, announced today that after completing its review of safety ...
|
|
Related Articles |
|
|
|
|
